Search Results - "Hoi, Alberta"

Global epidemiology of systemic lupus erythematosus by Barber, Megan R. W., Drenkard, Cristina, Falasinnu, Titilola, Hoi, Alberta, Mak, Anselm, Kow, Nien Yee, Svenungsson, Elisabet, Peterson, Jonna, Clarke, Ann E., Ramsey-Goldman, Rosalind

“…Systemic lupus erythematosus (SLE) is an autoimmune disease with protean manifestations that predominantly affects young women. Certain ethnic groups are more…”
Get full text

Definition and initial validation of a Lupus Low Disease Activity State (LLDAS) by Franklyn, Kate, Lau, Chak Sing, Navarra, Sandra V, Louthrenoo, Worawit, Lateef, Aisha, Hamijoyo, Laniyati, Wahono, C Singgih, Chen, Shun Le, Jin, Ou, Morton, Susan, Hoi, Alberta, Huq, Molla, Nikpour, Mandana, Morand, Eric F

“…Treating to low disease activity is routine in rheumatoid arthritis, but no comparable goal has been defined for systemic lupus erythematosus (SLE). We sought…”
Get more information

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus by Mende, Rachel, Vincent, Fabien B, Kandane-Rathnayake, Rangi, Koelmeyer, Rachel, Lin, Emily, Chang, Janet, Hoi, Alberta Y, Morand, Eric F, Harris, James, Lang, Tali

“…Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease characterized by biological and clinical heterogeneity. The interleukin (IL)-1…”
Get full text

Treatment Update in Systemic Lupus Erythematous by Hoi, Alberta Y., Morand, Eric F.

“…The recent updates on treatment recommendations for the management of systemic lupus erythematous have provided greater clarity in the way existing…”
Get full text

Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus by Godsell, Jack, Rudloff, Ina, Kandane-Rathnayake, Rangi, Hoi, Alberta, Nold, Marcel F., Morand, Eric F., Harris, James

“…Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the development of autoantibodies to nuclear antigens and inflammatory…”
Get full text

Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study by Golder, Vera, Kandane-Rathnayake, Rangi, Hoi, Alberta Yik-Bun, Huq, Molla, Louthrenoo, Worawit, An, Yuan, Li, Zhan Guo, Luo, Shue Fen, Sockalingam, Sargunan, Lau, Chak Sing, Mok, Mo Yin, Lateef, Aisha, Franklyn, Kate, Morton, Susan, Navarra, Sandra Teresa V, Zamora, Leonid, Wu, Yeong-Jian, Hamijoyo, Laniyati, Chan, Madelynn, O'Neill, Sean, Goldblatt, Fiona, Nikpour, Mandana, Morand, Eric Francis

“…Systemic lupus erythematosus (SLE) is associated with significant impairment of health-related quality of life (HR-QoL). Recently, meeting a definition of a…”
Get full text

Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know? by Eades, Laura E, Sines, Jason, Hoi, Alberta Y, Liddle, Ruaidhri, Kandane-Rathnayake, Rangi, Morand, Eric F, Brady, Stephen, Rischmueller, Maureen, Vincent, Fabien B

“…Autoimmune rheumatic disease (AIRD) is a collective term, which comprises a group of multisystem inflammatory autoimmune diseases, including connective tissue…”
Get full text

Enrolment of the first paediatric cohort into the Australian lupus registry and biobank: A single-centre experience by Power, Bronwyn D, Kandane-Rathnayake, Rangi, Tiller, Georgina, Renton, William D, Cox, Angela, Johnstone, Lilian, Hoi, Alberta, Gowdie, Peter

“…Introduction We aim to report on the feasibility of establishment of the first paediatric cohort as part of the longitudinal database of the Australian Lupus…”
Get full text

Routine testing for hyposplenism in a lupus clinic diagnoses; new cases and opportunities for intervention by Ko, Tina, Yeo, Ai Li, Luu, Sarah, Dendle, Claire, Woolley, Ian, Morand, Eric, Hoi, Alberta

Get full text

Associations of metabolic syndrome in SLE by Apostolopoulos, Diane, Vincent, Fabien, Hoi, Alberta, Morand, Eric

“…ObjectivesTo characterise the prevalence and associations of metabolic syndrome (MetS) in a multiethnic cohort of patients with SLE.MethodsUsing a standardised…”
Get full text

Algorithm for calculating high disease activity in SLE by Hoi, Alberta, Nim, Hieu T, Koelmeyer, Rachel, Sun, Ying, Kao, Amy, Gunther, Oliver, Morand, Eric

“…Abstract Background The ability to identify lupus patients in high disease activity status (HDAS) without knowledge of the SLEDAI could have application in…”
Get full text

The art of managing medical uncertainty by Johnson, Paul, Prof, Hoi, Alberta, FRACP

“…Persistent fever in a 30-year-old man should prompt a careful search for a travel-related, environmental, or sexually transmitted infection, and, if selected…”
Get full text

Disease course following High Disease Activity Status revealed patterns in SLE by Hoi, Alberta, Koelmeyer, Rachel, Bonin, Julie, Sun, Ying, Kao, Amy, Gunther, Oliver, Nim, Hieu T, Morand, Eric

“…We sought to examine the disease course of High Disease Activity Status (HDAS) patients and their different disease patterns in a real-world longitudinal…”
Get full text

Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study by Sreedharan, Sidha, Li, Ning, Littlejohn, Geoff, Buchanan, Russell, Nikpour, Mandana, Morand, Eric, Hoi, Alberta, Golder, Vera

“…Abstract Background Healthcare quality for systemic lupus erythematosus (SLE) is a modifiable target for improving patient outcomes. We aimed to assess the…”
Get full text

Quality of Care for Systemic Lupus Erythematosus: Mind the Knowledge Gap by Golder, Vera, Morand, Eric F, Hoi, Alberta Y

“…Systemic lupus erythematosus (SLE) is a prototypical chronic multiorgan autoimmune disorder that can lead to significant burden of disease and loss of life…”
Get full text

Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis by Northcott, Melissa, Jones, Sarah, Koelmeyer, Rachel, Bonin, Julie, Vincent, Fabien, Kandane-Rathnayake, Rangi, Hoi, Alberta, Morand, Eric

“…ObjectivesType 1 interferon (IFN) is key to the pathogenesis of SLE, evidenced by the expression of IFN-stimulated genes (ISGs) in most patients, but the…”
Get full text

LP-067 Analysis of hospital length of stay in systemic lupus erythematosus patients hospitalised with infection by Butala, Anant, Li, Ning, Hoi, Alberta

“…BackgroundSerious infections contribute significantly to morbidity and mortality in systemic lupus erythematosus (SLE)MethodsWe undertook a retrospective…”
Get full text

Smith-specific regulatory T cells halt the progression of lupus nephritis by Eggenhuizen, Peter J., Cheong, Rachel M. Y., Lo, Cecilia, Chang, Janet, Ng, Boaz H., Ting, Yi Tian, Monk, Julie A., Loh, Khai L., Broury, Ashraf, Tay, Elean S. V., Shen, Chanjuan, Zhong, Yong, Lim, Steven, Chung, Jia Xi, Kandane-Rathnayake, Rangi, Koelmeyer, Rachel, Hoi, Alberta, Chaudhry, Ashutosh, Manzanillo, Paolo, Snelgrove, Sarah L., Morand, Eric F., Ooi, Joshua D.

“…Antigen-specific regulatory T cells (Tregs) suppress pathogenic autoreactivity and are potential therapeutic candidates for autoimmune diseases such as…”
Get full text

Primary aldosteronism: an unsuspected culprit of hypertension in systemic lupus erythematosus? by Feng, Grace S, Kent, Joanna R, Fuller, Peter J, Hoi, Alberta Y, Kitching, A Richard, Yang, Jun, Vincent, Fabien B

“…Primary aldosteronism (PA) is the most common endocrine cause of secondary hypertension and is associated with a high risk of cardiovascular disease in the…”
Get more information

The need to define treatment goals for systemic lupus erythematosus by Franklyn, Kate, Hoi, Alberta, Nikpour, Mandana, Morand, Eric F.

“…Active systemic lupus erythematosus (SLE) can manifest in heterogeneous clinical forms, making description of SLE clinical states difficult in patients with…”
Get full text